Connect
MJA
MJA

Pharmaceutical preparations

Research

Stroke risk and NSAIDs: an Australian population-based study

Gillian E Caughey, Elizabeth E Roughead, Nicole Pratt, Graeme Killer and Andrew L Gilbert

Med J Aust 2011; 195 (9): 525-529 Free

Editorials

NSAIDs and stroke risk

David J Blacker

Med J Aust 2011; 195 (9): 488

Perspectives

The downsides of antidepressants

Ray Moynihan

Med J Aust 2011; 195 (8): 441

Editorials

Why is disulfiram not on the PBS?

Wendy L Lipworth, Alex D Wodak, Paul S Haber and Richard O Day

Med J Aust 2011; 195 (7): 371-372

Letters

Pharmacogenetic screening of Indigenous Australians

Joseph D Tucci

Med J Aust 2011; 195 (7): 386-387 Free

Editorials

Safety of incretin-based therapies for type 2 diabetes

Timothy M E Davis

Med J Aust 2011; 195 (6): 312-313

Letters

Should opioids be used for chronic non-cancer pain?

Mark S Awerbuch

Med J Aust 2011; 195 (5): 264-265

Research

Persistence with a single pill versus two pills of amlodipine and atorvastatin: the Australian experience, 2006–2010

Leon A Simons, Michael Ortiz and Gordon Calcino

Med J Aust 2011; 195 (3): 134-137 Free

Editorials

Improving Aboriginal and Torres Strait Islander people’s access to medicines — the QUMAX program

Sophie Couzos, Vicki Sheedy and Dea Delaney Thiele

Med J Aust 2011; 195 (2): 62-63 Free

Letters

Death and morbidity from supratherapeutic dosing of colchicine

Myles W H Smith, Darren M Roberts, Siobhann M Ritson and Richard O Day

Med J Aust 2011; 194 (11): 612-613

Letters

High-dose intravenous flucloxacillin may affect warfarin therapy

Philip Y-I Choi, Katherine L Phillips and Ian Rae

Med J Aust 2011; 194 (11): 613

Editorials

Saving money on the PBS: ranibizumab or bevacizumab for neovascular macular degeneration?

Ken J Harvey, Richard O Day, William G Campbell and Wendy Lipworth

Med J Aust 2011; 194 (11): 567-568

Notable cases

Extensively drug-resistant tuberculosis: New Zealand’s first case and the challenges of management in a low-prevalence country

Tze Liang Goh, Cindy R Towns, Katharine L Jones, Joshua T Freeman and Colin S Wong

Med J Aust 2011; 194 (11): 602-604 Free

Lessons from practice

Anticonvulsant hypersensitivity syndrome: a rare and serious complication

Isaac Schweitzer

Med J Aust 2011; 194 (11): 609-610 Free

Letters

Misuse of codeine-containing combination analgesics

Michael A McDonough

Med J Aust 2011; 194 (9): 486

Lessons from practice

A case of hepatitis attributable to repeated exposure to methoxyflurane during its use for procedural analgesia

Kacey M O’Rourke, Stuart McMaster and Karin M C Lust

Med J Aust 2011; 194 (8): 423-424 Free

Letters

Cough mixture dependence and stroke: implications for pseudoephedrine regulation

Ajay Bharatula and Peter W New

Med J Aust 2011; 194 (8): 427

Notable cases

Severe infection with Clostridium difficile PCR ribotype 027 acquired in Melbourne, Australia

Michael Richards, James Knox, Briony Elliott, Kate Mackin, Dena Lyras, Lynette J Waring and Thomas V Riley

Med J Aust 2011; 194 (7): 369-371 Free

Conference report

Antibiotic resistance is an emerging threat to public health: an urgent call to action at the Antimicrobial Resistance Summit 2011

Thomas Gottlieb and Graeme R Nimmo

Med J Aust 2011; 194 (6): 281-283

Notable cases

Life-threatening hypokalaemia associated with ibuprofen-induced renal tubular acidosis

Jennifer L Ng, David J R Morgan, Nelson K M Loh, Seng K Gan, Patrick L Coleman, Gregory S Y Ong and David Prentice

Med J Aust 2011; 194 (6): 313-316 Free

Letters

Bipolar disorder supplement needed broader perspective

Jon N Jureidini, Peter I Parry, Catherine M Houen and Malcolm W Battersby

Med J Aust 2011; 194 (6): 326

Letters

Bipolar disorder supplement needed broader perspective

David J Castle, Michael Berk and Barbara M Hocking

Med J Aust 2011; 194 (6): 326

Letters

A 2009 survey of psychotropic medication use in Sydney nursing homes

John Snowdon, Daniel Galanos and Divya Vaswani

Med J Aust 2011; 194 (5): 270-271

Letters

Use of mifepristone for medical abortion in Australia, 2006–2009

Caroline M de Costa

Med J Aust 2011; 194 (4): 206-207

Letters

Managing residual risk in patients receiving statin therapy

Marilyn K Mann

Med J Aust 2011; 194 (1): 54